Johnson and Johnson Announces 2025 Second Quarter Financial Results, Raises Full-Year Sales Guidance, Lowers Tariff Costs Outlook
Published on July 17, 2025
NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) yesterday announced financial results for the second quarter of 2025, reporting sales growth of 5.8 percent in the second quarter to $23.7 billion, with operational growth of 4.6 percent and adjusted operational growth of 3.0 percent. In the company’s MedTech segment, vision grew 6.5 percent in the second quarter with operational growth of 4.6 percent year-over-year, the announcement said. The company said it is increasing its full year estimated reported sales guidance at the midpoint by $2 billion dollars to 5.4 percent. Estimated reported sales for 2025 are now expected to be in a range of between $93.2 billion to $93.6 billion.